Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said
Advertisement

Related Content

PhamAsia News Top Editors' Picks Of 2010
South Korea's Health Ministry Unveils Provisions For November's Anti-rebate Law
Korea's Dong-A Regains Top Spot From Green Cross In Q2 Sales
Korea's National Tax Service Adds Momentum To Government Drive Against Rebates; 18 Pharmas Taxed, MNCs Also?
South Korean Pharmas Clamber For Partnerships To Survive Rapidly Changing Environment
Korea's Hanmi And Merck Move To Sell Hanmi's Hypertension Drug In North America, China and Europe
Korea's Hanmi And Merck in Discussion to Sell Hanmi's Hypertension Drug In Other Countries including Six Asia-Pacific Countries
GSK Expands In Korea With Purchase Of 9.9 Percent Equity Stake In Dong-A Pharma
Generics of Complex Drugs Must Pass Korea FDA's Bioequivalence Test; Another Positive Development for MNCs
Korea Pharma Manufacturing Association Takes Steps To Snag Unethical Member Companies
Advertisement
UsernamePublicRestriction

Register

SC074946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel